Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program.
J PakenC D GovenderVikash SewramPublished in: BMC women's health (2017)
This study is the first longitudinal study in South Africa to determine the ototoxic effects of cisplatin therapy on patients diagnosed with cervical cancer. Thus, the results generated from this study is likely to bring novel information to the fore using an evidence-based approach that will influence policy and clinical practice which can vastly improve the quality of life of patients undergoing chemotherapy. Mitigation of any further loss in the quality of life of affected patients is of paramount importance and the data generated from this project can lay the basis for further effective dialogue towards policy formulation on an ototoxic monitoring programme and the resultant strengthening of health systems in limited resource settings.
Keyphrases
- end stage renal disease
- south africa
- patients undergoing
- newly diagnosed
- ejection fraction
- healthcare
- peritoneal dialysis
- public health
- quality improvement
- clinical trial
- mental health
- stem cells
- squamous cell carcinoma
- climate change
- locally advanced
- drug delivery
- big data
- mesenchymal stem cells
- hepatitis c virus
- artificial intelligence
- bone marrow
- lymph node metastasis
- health information
- electronic health record
- replacement therapy